TB-500 (Thymosin Beta-4)
Investigational synthetic Thymosin Beta-4-related peptide (regenerative) · Pre-filled pen
TB-500 is a synthetic peptide associated with Thymosin Beta-4 activity. In animal and cell studies it is linked to regulation of actin, cell migration, angiogenesis and modulation of inflammation, which together support tissue re-organisation during repair. Robust controlled human trials are lacking, so its recovery claims remain research-level.
Studied use areas
- Musculoskeletal and soft-tissue recovery (research context)
- Connective-tissue resilience
- Cell migration and tissue remodelling
- Angiogenesis and tissue perfusion
- Inflammation balance during recovery
Safety & status
- Investigational and not an approved medicine; controlled human safety data are lacking
- Prohibited in competitive sport under the WADA prohibited list
- Product purity and source quality can vary and affect risk
- Use only under qualified physician oversight
⚕ Clinical note: This card is educational and is not medical advice. TB-500 is investigational; any use must be individualised and determined by the treating physician.
Evidence: Investigational — mainly animal and cell data; no approved human indication · References: peer-reviewed regenerative-medicine and preclinical tissue-repair literature; EMA/MHRA regulatory-status information on unapproved peptides; sports anti-doping (WADA) prohibited-substance listings




